Antibiotic resistance market seen reaching $18.22 billion by 2030

The antibiotic resistance market is projected to grow from $13.73 billion in 2026 to $18.22 billion by 2030, driven by rising drug-resistant infections, diagnostics adoption and antimicrobial R&D. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - Antibiotic resistance is making infections harder to treat and raising the risk of severe outcomes, including death. - The market growth reflects rising demand for new drugs, diagnostics and surveillance tools to respond to resistant pathogens. - Increased deaths from antibiotic-resistant infections in the UK underscore the public health pressure behind the market expansion.

What happened: - The Business Research Company said the antibiotic resistance market will rise from $12.85 billion in 2025 to $13.73 billion in 2026. - The report projects the market will reach $18.22 billion by 2030, implying a 7.3% compound annual growth rate. - The company released its Antibiotic Resistance Market Report 2026 covering market size, trends and a global forecast for 2026-2035. - The report includes regional analysis across Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company also published a free sample and the full report online: Free sample and the full report.

The details: - Historical growth was linked to widespread antibiotic misuse, hospital-acquired infections, broader use of broad-spectrum antibiotics, a limited pipeline of new antibiotics and more resistant pathogens. - Future growth is expected to come from increased funding for antimicrobial R&D, wider use of precision diagnostics, expansion of global resistance surveillance, stronger interest in alternative therapies and more public-private collaboration. - Key market trends include faster development of novel antibiotics, greater use of combination therapies, rapid diagnostic technologies, broader antimicrobial stewardship programs and improved monitoring of resistant pathogens. - Antimicrobial resistance occurs when bacteria, fungi and other microorganisms evolve to survive medicines designed to eliminate them. - Drug-resistant infections caused by bacteria that no longer respond to standard antibiotics create major treatment challenges. - Antimicrobial resistance drugs are used to improve treatment outcomes by targeting resistant and non-resistant pathogens, depending on resistance mechanisms and microbiome interactions. - UK Health Security Agency data showed deaths from antibiotic-resistant infections rose from 2,041 in 2023 to 2,379 in 2024, an increase of 338 deaths in one year. - North America was the largest regional market in 2025, supported by advanced healthcare infrastructure and substantial R&D investment. - Asia-Pacific is expected to be the fastest-growing region during the forecast period because of expanding healthcare access and rising awareness.

Between the lines: - The report points to a market shaped less by routine pharmaceutical demand and more by a widening clinical threat that requires diagnostics, stewardship and treatment innovation. - The focus on precision diagnostics and surveillance suggests buyers are looking beyond antibiotics alone toward systems that can detect and track resistance faster. - Growth in alternative therapeutic approaches signals that the market is broadening as the antibiotic pipeline remains constrained.

What's next: - The market is expected to keep expanding as governments, healthcare systems and drug developers respond to resistant infections. - More investment in antimicrobial research, faster diagnostics and surveillance networks is likely to shape product development and procurement decisions. - The company said its 2026 report series adds market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel forecasting dashboards and hotspot infographics. - The Business Research Company also directed readers to its website and social channels for more information.